Current Issue

Vol 1, No 1

Current Issue

Articles

29,943

Views

20,604

Downloads

In Press

Published

Published: In Press

Pages: 1-16

Submit Your Research

Fair & Rigorous Review • Open Access • Indexed & Discoverable

Submit Manuscript

In-brief

Pages: 1-5

In Vitro Activity of Iclaprim Against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid or Vancomycin

👤 Authors: B Huang David, Hawser Stephen, G. Gemmell Curtis + 1 more

Abstract: Iclaprim is a novel bacterial dihydrofolate reductase inhibitor in Phase 3 clinical development for the treatment of acute bacterial skin and skin structure infections and hospital acquired b... Read more

Abstract: Iclaprim is a novel bacterial dihydrofolate reductase inhibitor in Phase 3 clinical development for the treatment of acute bacterial skin and... Read more

Published: Aug 14, 2017

Pages: 1-5

👁️ Views: 8,829

📥 Downloads: 8,174 (PDF: 4,455, XML: 3,719)

Open Access

📖 View Article 📄 PDF 📝 XML

Research-article

Pages: 6-16

Characterization of rpoB Gene Mutations Associated with Rifampicin Resistance in Multidrug Resistant Tuberculosis Patients Co-infected with HIV from Southern India.

👤 Authors: K Jadhav Shivaji, R Mote Sanjay, Katarla Rajani

Abstract: Co-infection of HIV with Mycobacterium tuberculosis is a common event, particularly in developing countries. The emergence and spread of multidrug resistant tuberculosis (MDR-TB) is an increa... Read more

Abstract: Co-infection of HIV with Mycobacterium tuberculosis is a common event, particularly in developing countries. The emergence and spread of mult... Read more

Published: Jul 10, 2019

Pages: 6-16

👁️ Views: 21,114

📥 Downloads: 12,430 (PDF: 6,728, XML: 5,702)

Open Access

📖 View Article 📄 PDF 📝 XML